New award for buprenorphine HCL 2MG/naloxone HCL 0.5MG tab, sublingual with gsms. Ordering period is june 8, 2026 to june 7, 2027 with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0022
- Awardee
-
Golden State Medical Supply, Inc. UEI GQLDJJ8AQNN5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Buprenorphine Pre-solicitation notice Pre-Solicitation · 36E79726R0004 · Posted Dec 31, 2025
- Last date to order 73% complete
- IDV ceiling
- $20,977,433.71
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center awarded a single-award indefinite delivery contract to Golden State Medical Supply, Inc., for Buprenorphine HCL 2mg/Naloxone HCL 0.5mg sublingual tablets on June 8, 2026, with a ceiling of $20,977,433.71. The contract has no set-aside designation and is unrestricted.
Place of performance is the pharmaceutical manufacturing and distribution operation maintained by Golden State Medical Supply in Camarillo, California, serving the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's and DOD's Pharmaceutical Prime Vendor Programs.
The underlying solicitation (36E79726R0004) was issued in commercial item format under FAR Part 12 and sought a single responsible source capable of providing uninterrupted supply of the exact drug formulation in specified packaging. The procurement was structured as a one-year base period plus four one-year option periods, with estimated annual requirements totaling approximately 422,383 bottles across two dosage strengths: 171,239 bottles of the 2mg/0.5mg formulation and 251,144 bottles of the 8mg/2mg formulation, each in 30-count packaging.
The ordering period runs from June 8, 2026, through June 7, 2027, with ultimate completion on June 7, 2027. The contract is governed by NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0022?
36E79726D0022 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on June 8, 2026.
How much is contract 36E79726D0022 worth?
36E79726D0022's own ceiling is $20,977,434.
Who can order from contract 36E79726D0022?
36E79726D0022 is a single award indefinite delivery contract.
Was contract 36E79726D0022 competed?
The extent of competition for 36E79726D0022 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV